4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-023878
CHIEF OPERATING OFFICER sold 98,660 shares at an average $35.54 ($3,506,278)
- CHIEF OPERATING OFFICER acquired 98,660 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2025-09-04 | Option exercise 10b5-1 | +38,725 | $15.50 | $600,238 | 83,177 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-09-04 | Option exercise 10b5-1 | +46,546 | $15.52 | $722,394 | 129,723 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-09-04 | Sale 10b5-1 | −85,271 | $35.52 | $3,028,826 | 44,452 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-09-05 | Option exercise 10b5-1 | +13,389 | $15.52 | $207,797 | 57,841 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2025-09-05 | Sale 10b5-1 | −13,389 | $35.66 | $477,452 | 44,452 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-09-04 | Option exercise · Share Option 10b5-1 | −38,725 | 6,249 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-09-04 | Option exercise · Share Option 10b5-1 | −46,546 | 13,389 | D | ||
| Tessari Eben CHIEF OPERATING OFFICER | 2025-09-05 | Option exercise · Share Option 10b5-1 | −13,389 | 0 | D | ||
| Open-market sales · 98,660 sh · avg $35.54 · $3,506,278 | |||||||
Loading xslF345X05/form4-09082025_080944.xml…